Finding new ALS biomarkers from nerve cells and blood
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study looks for new ways to detect and understand ALS by analyzing tiny nerve and blood markers. It may help find better treatments for ALS and related nerve diseases.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have ALS (diagnosed by a doctor using standard criteria) and your symptoms started within the last 2 years.
- Your lung function (FVC) is above 60%, and you do not have severe breathing or nutritional problems.
- You do not have serious liver or kidney disease, or any active infection or metabolic condition that could affect the test results.
- If you are at genetic risk for ALS (have a family history and a known genetic mutation) but have no symptoms, you may also be eligible.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for early signs of ALS in people with genetic risk, healthy controls, and people with early symptoms. It aims to find markers that could help diagnose ALS sooner.
This study collects blood, skin, and urine samples from people with ALS to build a cell bank and look for biomarkers—natural signs that might help track the disease or guide future treatments. It doesn't test a new drug, but it helps researchers learn more about ALS.
This study looks at a blood test to help doctors diagnose ALS (Lou Gehrig's disease). It tests a protein called neurofilaments that may show nerve damage. The study is for people suspected of having ALS, and the blood sample is taken as part of normal care.
This study is looking for proteins in blood and other body fluids that could help detect brain diseases like Parkinson's, Alzheimer's, and ALS early. It aims to improve diagnosis and future treatments.
This trial collects blood and spinal fluid samples from people being checked for ALS. The goal is to find clues (biomarkers) in tiny particles from nerve cells that could help doctors better understand and diagnose ALS.
This study is looking for biological markers in the blood that can help monitor how ALS progresses and potentially detect it earlier. By participating, you may help improve future diagnosis and care for ALS patients.
Hear when a new Amyotrophic Lateral Sclerosis (ALS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.